'An emerging malignancy': Cancer linked to these breast implants no longer 'rare', data suggests Social Sharing
2020-01-14 from cbc.ca
A cancer in women with textured breast implants is more widespread than previously believed, raising questions for patients and physicians about continuing to describe it as "rare."
As of Dec. 20, 2019, Health Canada said it had received 106 reports describing "breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)," including both confirmed and suspected cases. Of those, 52 were received since May 28, 2019.
That's double the 26 confirmed Canadian cases the regulator said it had received before last May.
"Two incident reports received after May 28, 2019 cite the outcome of death suspected to be associated with BIA-ALCL but those have yet to be confirmed," Health Canada said in an email in response to questions from CBC News.
Health Canada describes BIA-ALCL on its website as "a serious but rare" type of non-Hodgkin's lymphoma (a cancer that affects the immune system) that may develop many months or years after a breast implant procedure.
On May 28, 2019, the agency officially banned the sale and import of Biocell macrotextured breast implants produced by the company Allergan, due to an increased risk of BIA-ALCL associated with their use.
Read more here